4th Quarter - Report

QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED

Firm
Client
Income
—
Expenses
$260,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Zika Emergency Funding Authorization.

LobbyistCovered position, as disclosed
DOLLY A JUDGE —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; President of the U.S.

Medicare/Medicaid MMM

Medicare reimbursement related to the Physician Fee Schedule and Clinical Laboratory Fee Schedule (no specific bills), self-referral abuses relating to anatomic pathology (Promoting Integrity in Medicare Act of 2013, H.R. 2914), and Patient Protection and Affordable Care Act implementation.

LobbyistCovered position, as disclosed
DOLLY A JUDGE —

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); President of the U.S.; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2914 (114th)

Medical/Disease Research/Clinical Labs MED

FDA regulation of laboratory developed tests. HR 6, 21st Century Cures Act and PL 111-148, Patient Protection and Affordable Care Act implementation.

LobbyistCovered position, as disclosed
DOLLY A JUDGE —

Contacted: SENATE; Health & Human Services, Dept of (HHS); President of the U.S.; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.